Work

Abstract PS3-11-26: A real-world study of pyrotinib as neoadjuvant therapy for HER2-positive breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-11-26

Authors: H. Zheng, Y. Tan, Q. Zhang, J. Li, H. Shen, G. Wang, Y. Tu, Y. Yang, J. Liu, J. Wang, R. Tian, X. Fu, X. Wu

Institutions: Hubei Cancer Hospital, Huazhong University of Science and Technology, China Three Gorges University, Jingzhou Central Hospital, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, The Central Hospital of Xiao gan, Wuhan University of Science and Technology, Hubei University of Medicine, Taihe Hospital, Renmin Hospital of Wuhan University

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130688987

Cites:

Cited by:

Related to: